Application of four pricing models for orphan medicines: a case study for lumasiran

Abstract Background The combination of high prices and uncertain effectiveness is a growing challenge in the field of orphan medicines, hampering health technology assessments. Hence, new methods for establishing price benchmarks might be necessary to support reimbursement negotiations. In this stud...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Noa Rosenberg, Evert Manders, Sibren van den Berg, Lisa J. Deesker, Sander F. Garrelfs, Saco J. de Visser, Jaap W. Groothoff, Carla E. M. Hollak
Format:	Artigo
Sprog:	Inglês
Udgivet:	BMC 2024-12-01
Serier:	Orphanet Journal of Rare Diseases
Fag:	Pricing models Lumasiran Orphan medicinal products Primary hyperoxaluria type 1
Online adgang:	https://doi.org/10.1186/s13023-024-03446-w
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!